Astellas Pharma Global Development, Inc. clinical trials

A subsidiary of Astellas Pharma Inc

The registry lists 207 studies whose lead sponsor is Astellas Pharma Global Development, Inc.. 24 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 207. List all 207 → · All Astellas Pharma Inc studies →

• A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)RecruitingNCT07140016Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsRecruitingNCT07287995Phase 1/2

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their BladderRecruitingNCT07475806Phase 2

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric CancerRecruitingNCT07673887Phase 3

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve DamageRecruitingNCT07770685Phase 1/2

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerRecruitingNCT05997615Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerRecruitingNCT06901531Phase 3

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D MutationRecruitingNCT07566052Phase 3

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Learn How Stargardt-type Eye Conditions Progress in Children and AdultsRecruitingNCT07425574

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)RecruitingNCT07566156Phase 3

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate CancerRecruitingNCT07783282Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Learn How ASP3082 is Processed in Healthy MenRecruitingNCT07773129Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsRecruitingNCT07488676Phase 1/2

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerRecruitingNCT07409272Phase 3

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of Zolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With Gastric CancerNot yet recruitingNCT07829757Phase 4

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid TumorsRecruitingNCT07730021Phase 1/2

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic CancerRecruitingNCT05365581Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate CancerRecruitingNCT07005154Phase 2

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal CancerRecruitingNCT07024615Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial CancerRecruitingNCT06862219Phase 4

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of ASP1002 in Adults for Treatment of Solid TumorsRecruitingNCT05719558Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate CancerRecruitingNCT07339267Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate CancerRecruitingNCT04729114Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• Early Access Program for ZolbetuximabAvailableNCT06048081

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.Active, not recruitingNCT03504397Phase 3

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic CancerActive, not recruitingNCT06396091Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic CancerActive, not recruitingNCT03816163Phase 2

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney DiseaseActive, not recruitingNCT05970172Phase 3

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyActive, not recruitingNCT02960022Phase 2

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor OveractivityCompletedNCT05621616Phase 3

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).Active, not recruitingNCT03653507Phase 3

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)Active, not recruitingNCT04225117Phase 2

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic AtrophyActive, not recruitingNCT06779773

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone TherapyActive, not recruitingNCT06440967Phase 3

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)TerminatedNCT05014139Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's SyndromeTerminatedNCT06544642Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid LeukemiaActive, not recruitingNCT05520567Phase 1/2

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust MitesActive, not recruitingNCT04184895Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of Zolbetuximab (IMAB362) in Adults With Gastric CancerActive, not recruitingNCT03505320Phase 2

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of ASP1012 in Adults With Solid TumorsTerminatedNCT06171178Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy AdultsActive, not recruitingNCT07395024Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid TumorsTerminatedNCT05083481Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.Active, not recruitingNCT06792435Phase 1/2

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4CompletedNCT02091999Phase 1

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard ChemotherapyCompletedNCT02752035Phase 3

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night SweatsCompletedNCT06049797

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial CancerActive, not recruitingNCT04223856Phase 3

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• Avacincaptad Pegol Open-Label Extension for Patients With Geographic AtrophyCompletedNCT05536297Phase 3

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)CompletedNCT03364153Phase 2

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.

• A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial CancerTerminatedNCT03288545Phase 1/2

  Sponsor listed in the registry: Astellas Pharma Global Development, Inc.